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READER’S OPINION
Certifying achievement in the control of Chagas  
disease native vectors: what is a viable scenario?
Ken Hashimoto1,2/+, Kota Yoshioka3
1Takemi Program in International Health, Harvard School of Public Health, Boston, MA, USA  
2Former Regional Adviser for Chagas Disease Control in Central America  
3Former Expert for Chagas Disease Control Project in Nicaragua, Japan International Cooperation Agency
As an evaluation scheme, we propose certifying for “control”, as alternative to “interruption”, of Chagas disease 
transmission by native vectors, to project a more achievable and measurable goal and sharing good practices through an 
“open online platform” rather than “formal certification” to make the key knowledge more accumulable and accessible.
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The recent papers by Abad-Franch et al. (2013) and 
Salvatella et al. (2014) discussed the approach for certi-
fication in the control of Chagas disease native vectors, 
referring to the situations in South America. We consider 
that most of the arguments are relevant and timely also 
for Central America. With intensions to enrich the discus-
sions held so far principally from scientific and political 
viewpoints, we will be providing the third dimension, an 
operational perspective, based on the experiences from 
the control of Triatoma dimidiata in Central America. 
The term “operational” in this paper is expected to de-
note technical and financial practicality for low-budget-
ed countries to combat this neglected tropical disease.
After successful vector control interventions against 
Rhodnius prolixus, T. dimidiata became the main vec-
tor of Chagas disease in Central America (Cedillos et al. 
2012, Hashimoto & Schofield 2012, IPCA 2012). T. di- 
midiata with the origin in Peninsula of Yucatan in Mexico 
and Guatemala is found extensively from sylvatic to do-
mestic areas throughout the region (Bargues et al. 2008). 
The vector has been reported in 21 of 22 departments in 
Guatemala, 14 of 14 departments in El Salvador, 13 of 
18 departments in Honduras and 15 of 17 departments in 
Nicaragua (Tabaru et al. 1999, JICA 2014a).
Guatemala,  El  Salvador,  Honduras  and  Nicaragua 
implemented vector control interventions with technical 
assistance of Japan International Cooperation Agency 
(JICA) since 2000 and made a notable progress in the 
control of T. dimidiata (JICA 2014a). The initial target set 
by the Initiative of the Countries of Central America for 
Control of Vector-Borne and Transfusional Transmission 
of Chagas Disease (IPCA) was to reduce the house infes-
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tation index of T. dimidiata to below 5% (PAHO 2002). 
Recently few departments report over 5% according to 
the countries’ presentations in IPCA annual meetings: 
two in Guatemala, four in El Salvador, five in Honduras 
and two in Nicaragua, though these data are not statisti-
cally representative (IPCA 2012, IPCAM 2013).
The reduction of house infestation index owes pri-
marily to the indoor insecticide spraying; however, per-
sistent reinfestation of T. dimidiata is observed in certain 
endemic areas even after multiple cycles of insecticide 
spraying (Hashimoto et al. 2006, 2012). Such repeated re-
infestation implies that the risk of vector-borne transmis-
sion remains as threat to the population. Effectively, acute 
Chagas cases are sporadically, but continually reported 
from different parts of Central America including from 
those intervened (JICA 2014a, Sasagawa et al. 2014).
Due to the recurrent transmission risk, the core con-
trol strategy have shifted from massive insecticide spray-
ing (attack phase) to entomological surveillance and se-
lective response (surveillance phase). In the four Central 
American countries, the Ministries of Health have imple-
mented community-based surveillance and response sys-
tems in order to address vector reinfestation with limited 
human and financial resources under decentralised health 
systems (Hashimoto & Yoshioka 2012, JICA 2014a). For 
example, the Nicaraguan Ministry of Health through the 
surveillance response system received vector reports from 
1,495 households in the northern five departments from 
July-December in 2013. As response, the local health per-
sonnel visited 1,293 (86.5%) households to provide pre-
ventive education. Among them, 443 households were 
categorised as eligible for insecticide spraying and 318 
(71.8%) were sprayed by institutional vector control per-
sonnel or trained community volunteers (JICA 2014b).
Under the circumstance described above, the goal of 
T. dimidiata control has been a point of discussion again. 
The sub-regional initiative in the annual meeting of 2013 
recommended  that  the  “interruption  of  Trypanosoma 
cruzi transmission by T. dimidiata in human dwellings” 
would be a renovated objective (IPCAM 2013). The in-
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dren aged between one-15 years old (optionally the target 
age could be between 0-5 years old). The entomological 
information could be a reference, but not determinant, 
to demonstrate the interruption of T. cruzi transmission. 
Achievement of the following indicators is encouraged: 
(i) combined indoor and peridomestic infestation index 
to be lower than 5%, (ii) indoor infestation index reduced 
to less than 2% and (iii) more than 50% of reduction in 
the percentage of infested villages or dispersion index at 
municipality level (IPCAM 2013). Apparently, these cri-
teria derive from experiences of vector control in South 
America,  where  the  interruption  of  transmission  was 
technically  achievable  in  most  parts.  However,  some 
closer speculations may be necessary to adapt the crite-
ria to the control of T. dimidiata in Central America.
To deliberate upon the interruption of T. cruzi trans-
mission by native vectors, the arguments of Abad-Franch 
et al. (2013) and Salvatella et al. (2014) marked important 
implications. We consider that fundamental concepts are 
shared between two sides in the discussion. Firstly, the 
operational interventions must be continued to minimise 
the infection risks. As the native vectors are not elim-
inable and could reinfest human dwellings, the entomo-
logical surveillance and response system must be sus-
tained. Secondly, there is a need to reestablish a regional 
evaluation mechanism for the control of native species. 
Yet, since the existing framework was developed on the 
basis of experiences of controlling eliminable vectors, 
such as Triatoma infestans in major parts of South Amer-
ica and R. prolixus in Central America, its focus lacks in 
emphasis on sustainability of the control efforts.
So, how better can we certify the control of native 
vectors? What are the pros and cons of the certification? 
These are the central questions worth readdressing to.
Salvatella et al. (2014) maintain the standpoint that 
the traditional scheme of certifying the interruption of 
transmission of T. cruzi (CIT) should also be applied for 
the control of native species. Rationale for the CIT is 
the power of numbers. The CIT provides the countries 
with clear and common goals which may increase the 
governments’ political will and financial resources. As 
Salvatella et al. (2014) repeatedly stress, the CIT in real-
ity successfully produced positive impacts on the con-
trol of eliminable vectors in South and Central America. 
Indeed, the CIT organised by the subregional initiatives 
politically and technically facilitated the member coun-
tries in preparation of national strategic plans and in-
volvement of donor agencies (JICA 2014a).
However, the CIT faces major challenges in Cen-
tral America as an evaluation scheme for the control of 
T. dimidiata. Firstly, the CIT does not demonstrate im-
probability of further incidence after the certification. 
Even though a cross-sectional serological survey reveals 
zero seroprevalence of a particular moment, the result is 
hardly valid thereafter, because of persistent transmis-
sion risks presented by the native vectors. Certifying 
a temporal interruption is impractical in the control of 
native vectors. Secondly, it is extremely demanding for 
the  Central  American  countries  to  obtain  convincing 
evidence to show the interruption of T. cruzi transmis-
sion. Because the native vectors are vastly distributed, 
the serological and entomological data must be collected 
from extensive geographical areas. The lower the target 
seroprevalence, the larger the sample size is required 
statistically to assure the representativeness. This im-
plies considerably high cost and financial burden for the 
affected low-budgeted countries. Thirdly, the collected 
data may misguide the certification. As Abad-Franch et 
al. (2014) point out from the scientific view, the sero-
logical surveys are prone to bias due to underestimation 
of at-risk population, limited samples by targeting only 
children and usage of filter paper or diluted glycerin. 
These methods are also used in Central America. Simi-
larly, with T. dimidiata, the entomological survey data 
could be biased because of unreported vectors and lack 
of sensibility in the vector search techniques (Monroy et 
al. 1998). Incomplete data analysis could certify appar-
ent interruption of T. cruzi transmission. For these rea-
sons, we consider that the CIT is not a suitable goal for 
the control of T. dimidiata in Central America.
The alternative by Abad-Franch et al. (2013) is to cer-
tify good practices (CGP) which could improve perfor-
mance of control programs through detecting and cor-
recting malfunctions. Abad-Franch et al. (2013) argues 
that the CGP would provide the countries with incentives 
to create ideas for problem solving and breakthrough, as 
well as operational images to improve program perfor-
mance and quality control. In their view, the CGP ben-
efits people at risk by strengthening control programs, 
while the CIT would benefit only health authorities. The 
CIT could weaken long-term control-surveillance sys-
tems, because the government can reduce the national 
budget  after  receiving  certification,  discontinue  the 
operational activities and consequently suffer from re-
emergence of the new T. cruzi transmission.
From the operational perspective, we agree that the 
CGP  could  continuously  improve  the  disease  control 
programs. To sustain the surveillance and response sys-
tems for the native vectors, a variety of maintenance is 
required to overcome different challenges such as lack 
of financial and human resources, data quality and com-
munity participation. If the good practices are replicated 
along with Plan-Do-Check-Act (PDCA) cycle to resolve 
these operational difficulties, the CGP may increase ef-
fectiveness, efficiency and sustainability of the control 
efforts at different levels of the Ministry of Health (JICA 
2014a). Nevertheless, the CGP may also bring about sev-
eral challenges. Firstly, the CGP could emphasise the 
importance of the process improvement, but would not 
give a clear indication of overall progress or long-term 
achievement. Secondly, good practices are likely to be 
evaluated with more subjective and biased criteria than 
CIT. The judgment of “good” depends on the personal 
value, as well as how the criteria are established and in-
terpreted by the evaluation mission. Thirdly, good prac-
tices tend to be context specific. Some practices could 
be unhelpful or even damaging in other circumstances. 
Moreover, the contexts are constantly changing. Proven 
but outdated practices may cause the curse of success. 
Such contextual peculiarity makes systematic evaluation 
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the Ministry of Health and evaluation teams. In our opin-
ion, the CGP could be too complex to gather momentum 
of the control efforts towards a common goal.
In practice, we consider that the countries require 
both result and process oriented evaluations for the na-
tive vector control. The CIT and CGP approaches are not 
contradictory, but rather synergic when integrated stra-
tegically. The long-term regional goals with evaluation 
provide clear direction and incentive to the countries, 
scientific  communities  and  donors.  Knowledge  man-
agement focused on good practices will improve per-
formance of the disease control activities. Hence, from 
the operational perspective, we suggest that a strategic 
scenario would be (i) to maintain the quantitative inter-
national certification system, but not for “interruption”, 
and (ii) to create a more accessible knowledge manage-
ment mechanism to facilitate sharing good practices.
Considering the persistent infection risks by the native 
vectors and limitations in demonstrating complete evi-
dence with serological surveys, an operationally achiev-
able point may be where Chagas disease transmission is 
controlled. By definition, “control” is “the reduction of 
disease incidence, prevalence, morbidity or mortality to 
a locally acceptable level as a result of deliberate efforts; 
continued intervention measures are required to maintain 
the reduction” (Dowdle 1998). The certification of control 
of transmission (CCT) as a regional goal would continue 
offering political incentives and long-term vision to the 
countries, but would avoid misleading both government 
and public towards discontinuation of the control efforts.
The CCT evaluation should require (i) seroprevalence 
among the children under 15 years old as the principal 
indicator and (ii) geographic coverage of surveillance on 
native vectors and acute cases as necessary conditions. 
When seroprevalence among the children is less than 
an established criterion, for example 1%, the transmis-
sion can be considered as “controlled”. The criterion is 
an arbitrary number in accordance with the local epide-
miological situation. As the control makes progress, the 
target figure could be gradually refined and lowered. For 
the entomological and acute case surveillance, the high-
er the potential infection risk the greater the geographic 
coverage should be. The surveillance coverage should be 
complete at least at the high risk areas.
To implement the CCT scheme, we recommend to 
scale down the target geographic area from a country to a 
smaller political division such as department or province 
(Hashimoto & Yoshioka 2012). This framework would 
facilitate  organisation  of  evaluation  activities  in  each 
country, by allocating limited resources to a particular 
area and by motivating the local personnel with a more 
achievable goal. Further, the country could generate a 
sense of competition among departments or provinces, 
which would stimulate the decentralised health systems 
to reinforce the control activities.
In view of sustaining the disease control efforts, the 
certification should be reversible (Hashimoto & Yoshioka 
2012). That is, the certification will be withdrawn, unless 
two essential requirements were fulfilled. One is that sero-
logical survey results should be presented to the subregion-
al initiative on a regular basis (e.g., every 5 years), showing 
that the seroprevalence is less than the established crite-
rion. The other is the sufficient coverage of entomological 
and acute case surveillance. The data should be collectable 
as part of routine surveillance activities and be presented 
at the annual meetings of the sub-regional initiative.
For  data  collection,  we  recommend  to  design  the 
sampling method strategically, rather than statistically, 
to  maximise  the  limited  available  resources.  For  ex-
ample, the sampling areas may be classified into high, 
medium and low risks within a department or province, 
according to the previous epidemiological records. The 
idea is to collect more serological samples from the high 
risk areas, followed by medium and low risk areas. This 
strategy is statistically opposite of what is required to 
demonstrate low seroprevalence and, unlike stratified 
sampling,  will  not  assure  representativeness  for  each 
risk group. However, to approach substantial geographic 
area with limited resources, searching for recent infec-
tion cases in high risk zones becomes more efficient 
than proving low seroprevalence throughout a vast land. 
The risk-focused approach should also facilitate the gov-
ernment officials justify their evaluation plans, claiming 
that the budgets would be spent for the most needed.
To improve quality of data analysis and increment 
objectivity of the certification, Abad-Franch et al. (2013) 
point out the importance of peer-review on the country’s 
report presented to the evaluation mission. From opera-
tional viewpoint, however, academia can contribute bet-
ter to the Ministry of Health, if they become involved at 
the designing stage of serological surveys and preparation 
for the country’s final report for CCT. When convincing 
evidence needs to be presented under limited resources, 
useful intellectual input would be highly appreciated.
For the process-oriented evaluation, exemplified prac-
tices may encourage knowledge creation, management 
and sharing, leading to improvement in the native vec-
tor control efforts. Instead of certifying good practices, 
a useful knowledge library should be established, where 
numerous different practices are archived in a concise and 
readily accessible manner. For instance, a simple online 
platform may be created for the public health practitio-
ners to upload their good practices for the others to view. 
To augment participation, each practice can be evaluated 
by clicking on a “like” icon or a “five-star-scaled” button 
by the viewers. The sub-regional initiatives may provide 
a prize or recognition on a regular basis for the countries 
to have reported the most highly valued practices in the 
library.  This  knowledge  management  platform  should 
also be administrated under the CCT mechanism.
In conclusion, the control of Chagas disease native 
vectors is an enduring challenge, where the subregional 
initiatives can greatly contribute to the countries’ efforts 
by providing result and process oriented evaluations. We 
recognise the importance of the goals being achievable 
technically  and  financially  and  therefore  propose  the 
certification of “control of T. cruzi transmission” as al-
ternative to the “interruption of T. cruzi transmission”. 
To maintain Chagas disease controlled, the interventions 
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ciency and sustainability. A key improvement strategy 
is integration of good practices into the health systems 
through the PDCA cycle. We agree on encouraging the 
knowledge management to create, replicate and share the 
good practices, but not by means of systematic evalua-
tion with international missions, rather by implementing 
a more practical and accessible platform such as online 
library for the public health professionals.
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